Cell Bauhaus
PrivateLast Round
Grant
Jan 28, 2025
Total Funding Raised
$5.2M
Company Overview
Cell Bauhaus operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Grant round in January 2025.
Cell Bauhaus is a software and biotechnology company that develops digital twins of biological cells to simulate and predict the effects of genetic changes on cellular behavior.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell Bauhaus Comparables
Compare Cell Bauhaus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metalytics | 84% | |
| Cytocast | 82% | |
| Netabolics | 82% |
For institutional investors. Book with your work email.
Cell Bauhaus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 28, 2025 | ||||
| Seed | Oct 8, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cell Bauhaus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Family Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| University of Melbourne | Seed |
| Tin Alley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
Secured $1.9M in grant funding.
- Oct 8, 2024
$2.2M round from Tin Alley Ventures and University of Melbourne.
For institutional investors. Book with your work email.
Cell Bauhaus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cell Bauhaus's valuation, stock price, and market status.
Is Cell Bauhaus a public or private company?
Cell Bauhaus is a private company.
What is the current stock price of Cell Bauhaus?
Cell Bauhaus is a private company, so its shares have no public market price. Caplight tracks Cell Bauhaus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cell Bauhaus worth (valuation)?
Valuation information for Cell Bauhaus is not publicly available.
Can I buy Cell Bauhaus stock?
Cell Bauhaus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cell Bauhaus's last funding round?
Cell Bauhaus's most recent funding round was Grant on January 28, 2025.
Who are the main investors in Cell Bauhaus?
Key investors in Cell Bauhaus include Gates Family Foundation, Bill & Melinda Gates Foundation, University of Melbourne, Tin Alley Ventures.
Will Cell Bauhaus IPO soon?
No public IPO plans have been announced for Cell Bauhaus.
How can I track Cell Bauhaus secondary market activity?
Caplight tracks bids, offers, and trades in Cell Bauhaus's shares on secondary markets.